부메뉴
USP/EP 해당 칼럼 찾기
| USP Method | Column | ||
|---|---|---|---|
| L32 | A chiral ligand-exchange resin packing-L-proline copper complex covalently bonded to irregularly shaped silica particles, 5 to 10 μm in diameter | Chiralpak WH |
|
| 1 | DOPA (Dihydroxy phenylalanine) | ||
| L40 | Cellulose tris-3,5-dimethylphenylcarbamate coated porous silica particles, 5 - 20 µm in diameter. | Chiralcel OD Chiralcel OD-H |
|
| 1 | Valsartan | ||
| 2 | Efavirenz | ||
| 3 | Sertraline Hydrochloride | ||
| 4 | Atomoxetine Hydrochloride | ||
| 5 | Irinotecan Hydrochloride | ||
| 6 | Timolol Maleate | ||
| 7 | Duloxetine Hydrochloride | ||
| 8 | Tiagabine Hydrochloride (Monographs) | ||
| 9 | Voriconazole | ||
| 10 | Tiagabine Hydrochloride (Monographs) | ||
| L41 | Immobilized alfa1-acid glycoprotein on spherical silica particles, 5 µm in diameter. | Chiral AGP | |
| 1 | Esomeprazole Magnesium | ||
| 2 | Montelukast Sodium | ||
| 3 | Rivastigmine | ||
| 4 | Ropivacaine Hydrochloride | ||
| 5 | Esomeprazole Magnesium | ||
| 6 | Galantamine Hydrobromide | ||
| 7 | Rivastigmine Tartrate | ||
| 8 | Benazepril Hydrochloride | ||
| 9 | Repaglinide | ||
| 10 | Tenofovir Disoproxil Fumarate | ||
| 11 | Tolterodine Tartrate | ||
| L51 | Amylose tris-3,5-dimethylphenylcarbamate-coated, porous, spherical, silica partilces, 5 to 10 µm in diameter. | Chiralpak AD Chiralpak AD-H |
|
| 1 | Fulvestrant | ||
| 2 | Meso-Zeaxanthin Preparation | ||
| 3 | Pramipexole Dihydrochloride | ||
| 4 | Paroxetine Hydrochloride | ||
| 5 | Levetiracetam | ||
| 6 | Meso-Zeaxanthin | ||
| 7 | Atorvastatin Calcium | ||
| 8 | Tamsulosin Hydrochloride | ||
| 9 | Brinzolamide | ||
| 10 | Tadalafil | ||
| 11 | *Abacavir Sulfate (Monographs) | ||
| 12 | Aprepitant | ||
| 13 | Dexchlorpheniramine Maleate | ||
| 14 | Efavirenz | ||
| 15 | Emtricitabine | ||
| 16 | Escitalopram Oxalate | ||
| 17 | Sitagliptin Phosphate | ||
| 18 | Zolmitriptan | ||
| L66 | A crown ether coated on a 5 µm particle size silica gel substrate. The active site is (S)-18-crown-6-ether. | Crownpak CR (+) | |
| 1 | Valacyclovir hydrochloride | ||
| 2 | Valacyclovir Tablets | ||
| 3 | Valganciclovir Hydrochloride | ||
| L70 | Cellulose tris(phenyl carbamate) coated on 5 µm silica. | Chiralcel OC-H | |
| 1 | Oxaliplatin | ||
| L75 | A chiral-recognition protein, bovine serum albumine (BSA), chemically bonded to silica particles, about 7 2µm in diameter, with a pore size of 300 Angstroms. | Chiralpak BSA | |
| 1 | Methorexate | ||
| L79 | A chiral-recognition protein, human serum albumin (HSA), chemically bonded to silica particles, about 5 µm in diameter. | Chiralpak HSA | |
| 1 | Calcium L-5-Methyltetrahydrofolate | ||
| L80 | Cellulose tris(4-methylbenzoate)-coated, porous, spherical, silica particles, 5 - 20 µm in diameter. | Chiralcel OJ Chiralcel OJ-H |
|
| 1 | Clopidogrel bisulfate | ||
| L90 | Amylose tris-[(S)-alpha-methylbenzylcarbamate] coated on porous, spherical silica particles, 3 to 10 µm in diameter. | Chiralpak AS Chiralpak AS-H Chiralpak AS-3 |
|
| 1 | Frovatriptan succinate | ||
| L93 | Cellulose tris(3,5-dimethylpheylcarbamate) reversed phase chiral stationary phase coated on 3 or 5 22m silica gel particles. | Chiralcel OD-R Chiralcel OD-3R |
|
| 1 | Ezetimibe | ||
| L99 | Amylose tris-(3,5)-dimethylphenylcarbamate), immobilized on porous, spherical, silica particles, 3 to 5 22m in diameter. | Chiralpak IA Chiralpak IA-3 |
|
| 1 | Darifenacin hydrobromide | ||
| L107 | Cellulose tris(4-methylbenzoate)-coated porous spherical particles, 3 to 5 µm in diameter, for use with reversed phase mobile phases. | Chiralcel OJ-RH |
|
| 1 | Rosuvastatin calcium | ||
| L108 | A chiral-recognition protein, cellobiohydrolase (CBH), chemically bonded to silica particles, about 5 µm in diameter. | Chiralpak CBH |
|
| 1 |
